RMMS consists of over 30 attorneys focused exclusively on life sciences patent and regulatory counseling, patent litigation under Hatch-Waxman and the BPCIA, as well as post-grant review before the PTAB. RMMS attorneys embrace the science of a case, and have made it an integral part of our strategy in the over 300 pharmaceutical litigation matters clients have entrusted to us. We understand that patent litigation is rarely an end-game, and that business decisions made throughout the product development, regulatory review, litigation, and commercialization process are equally critical to the company’s strategic plans involving any one product or a product portfolio. Content may include attorney advertising.